Skip to main content
Bloodstream infection system, assay from iCubate win FDA clearance
8/11/2017

The FDA has given molecular diagnostics firm iCubate clearance for the iC-System and the iC-GPC assay for rapid detection of bloodstream infections-related pathogenic bacteria. The system and the in vitro diagnostic test take up to 48 hours less than other tests to deliver results, the company said.

Full Story: